Procter & Gamble Hygiene and Health Care Limited Share Price

Equities

PGHH

INE179A01014

Personal Products

Delayed Bombay S.E. 12:30:39 18/05/2024 pm IST 5-day change 1st Jan Change
15,690 INR 0.00% Intraday chart for Procter & Gamble Hygiene and Health Care Limited +0.07% -9.58%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 * 42.32B 508M Sales 2025 * 46.37B 557M Capitalization 509B 6.12B
Net income 2024 * 7.88B 94.68M Net income 2025 * 8.92B 107M EV / Sales 2024 * 12 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 11 x
P/E ratio 2024 *
62.2 x
P/E ratio 2025 *
57.1 x
Employees 432
Yield 2024 *
1.45%
Yield 2025 *
1.49%
Free-Float 29.1%
More Fundamentals * Assessed data
Dynamic Chart
Procter & Gamble Hygiene Posts Decline in Fiscal Q4 Net Profit MT
Procter & Gamble Hygiene & Health Care's Net Profit Slips in Fiscal Q4 MT
Procter & Gamble Hygiene and Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
Analysis-In India's sizzling stock market, consumer stocks rise 18% but are laggards RE
Indian Equities Start Week in Black, Aided by Major Auto and Metal Firms MT
Procter & Gamble Hygiene and Health Care Limited Announces Cessation of Meena Ganesh as Independent Director CI
Procter & Gamble Hygiene & Health Care Managing Director to Step Down in April; Successor Named MT
Procter & Gamble Hygiene and Health Care Limited Announces Resignation of L. V. Vaidyanathan as Director, Effective April 30, 2024 CI
Procter & Gamble India Announces CEO Changes CI
Procter & Gamble Hygiene and Health Care Limited Appoints Ashima Goyal as Non- Executive Independent Director CI
India's P&G Hygiene posts jump in Q2 profit as lower costs offset dip in sales RE
Procter & Gamble Hygiene and Health Care Limited Announces Resignation of Karthik Natarajan as Non- Executive Director, Effective from Close of Business Hours of March 31, 2024 CI
Procter & Gamble Hygiene and Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Procter & Gamble Hygiene and Health Care Limited Declares an Interim Dividend for the Financial Year 2023-2024, Payable on or Before February 29, 2024 CI
Procter & Gamble Hygiene and Health Care Limited Declares Special Dividend for the Financial Year 2023-2024, Payable on or Before February 29, 2024 CI
More news

Latest transcript on Procter & Gamble Hygiene and Health Care Limited

1 week+0.07%
Current month-2.43%
1 month-1.60%
3 months-5.01%
6 months-14.69%
Current year-9.58%
More quotes
1 week
15 385.55
Extreme 15385.55
15 917.25
1 month
15 385.55
Extreme 15385.55
16 400.00
Current year
15 306.15
Extreme 15306.15
17 577.85
1 year
13 391.15
Extreme 13391.15
19 086.20
3 years
12 342.20
Extreme 12342.2
19 086.20
5 years
8 500.00
Extreme 8500
19 086.20
10 years
3 605.00
Extreme 3605
19 086.20
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 01/14/01
Compliance Officer - 01/18/01
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 77 18/13/18
Chairman 72 25/20/25
Director/Board Member 79 01/22/01
More insiders
Date Price Change Volume
18/24/18 15,690 +0.25% 13
17/24/17 15,650 -0.06% 122
16/24/16 15,660 -0.80% 202
15/24/15 15,786 +0.01% 77
14/24/14 15,785 +0.42% 417

Delayed Quote Bombay S.E., May 18, 2024 at 12:30 pm IST

More quotes
Procter & Gamble Hygiene and Health Care Limited is an India-based fast-moving consumer goods (FMCG). The Company is engaged in manufacturing and selling branded packaged FMCG in the feminine care and healthcare businesses. The Company has two segments: Health care products and Hygiene products. Health care products segment comprises ointment and creams, cough drops and tablets. Hygiene products segment comprises feminine hygiene products and other skin care hygiene products. It offers ayurvedic products, sanitary napkins, and deodorants. The Company’s brands portfolio includes Whisper, Vicks and Old Spice. Its product portfolio includes Whisper Choice XL, Whisper Choice Ultra, Vicks VapoRub, Vicks Throat Drops, Vicks Action 500 Advanced, Vicks Inhaler, Vicks Baby Rub growth and others. The Company's products are sold through retail operations, including mass merchandisers, grocery stores, membership club stores, drug stores, department stores and high-frequency stores.
Related indices
More about the company
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW